OXBRIDGE RE HOLDINGS Ltd (OXBR) Stock Analysis

Price updated 4 days ago · SEC data refreshed 3 months ago · Not investment advice

OXBRIDGE RE HOLDINGS Ltd

OXBR Financial Services Property & Casualty Insurance📄 SEC filings ↗
Speculative
▾ What's in the 62/100 risk score? (higher = riskier)
Valuation (price vs model IV) (43%) 92/100 → +39.4
Smart money (short interest + insider buying) (31%) 45/100 → +14.1
Macro backdrop (VIX, curve, credit, fear/greed + week-over-week momentum) (26%) 33/100 → +8.5
Total62/100

Contributions (weight × component score) sum to the total. This near-term score now includes fundamental health (leverage, FCF trend, DCF applicability). It excludes the Altman Z score, whose retained-earnings input this filer does not report separately. See the Financial Health section for the full balance-sheet read.

💵 Price $1.57 · 4 days ago 📄 Financials SEC EDGAR · refreshed 3 months ago

How to read OXBR (speculative micro-cap)

No model can pin a precise fair value on a company this small — but that does not mean there is nothing to learn. The useful questions are what the price is betting on, and whether the company can survive long enough to deliver it.

Where to start — the sections that matter most for this stock
  1. 1 Reverse-DCF — what growth the price assumes ↓
    The single most useful number here: it backs out the growth the market is paying for. If that figure is "historically unprecedented," the price is running on hype, not fundamentals.
  2. 2 Cash runway ↓
    A pre-profit micro-cap lives or dies on whether it can fund itself to profitability before running out of money and diluting you.
  3. 3 The raw financial statements + the 10-K ↓
    At this scale, the actual numbers, insider ownership, and share-count trend tell you more than any ratio.
Or — what are you trying to decide?
A note on process: fear-driven decisions — including fear of missing out — tend to be the expensive ones. A stock up 10% a day for three days is excitement, not evidence. Whichever reader you are, the data below is there to be checked before anything is decided.
🚀
"It's surging — should I chase it?"
The momentum / FOMO trade. Before you chase, see whether the people who know it best are quietly selling into the rally.
⚖️
"Is it worth what it costs?"
The valuation trade. Our DCF, the growth the price implies, and a calculator you drive yourself.
🏷️
"Is it a cheap bargain?"
The deep-value trade. How far below assets and our value it trades — and whether it's cheap for a reason.
ⓘ Why does OXBR trade at $1.57?

OXBRIDGE RE HOLDINGS Ltd has 7.4 million shares outstanding. At $1.57 per share, the market values all outstanding OXBR equity at $12 million. That's market capitalization, not enterprise value — enterprise value also accounts for debt and cash (for a bank or insurer, borrowings and deposits are the raw material of the business, so enterprise value isn't a meaningful yardstick — the bank lens below uses book value and returns instead). The share price by itself tells you almost nothing — a company can pick any share price by splitting or issuing more shares. What matters is the total value (Market Cap?Market Cap — The total dollar value the market is assigning to the entire company.
Why it matters: This is the number that actually matters when comparing companies. Two companies with the same business but different share counts have the same market cap.
Reference: Mega cap >$200B · Large $10–200B · Mid $2–10B · Small $300M–2B · Micro <$300M
Full explanation →
) compared to what the business actually produces. This page values OXBR in Per Share?Per Share — A company-level figure divided by total shares — what one share represents.
Why it matters: Per-share metrics are the only way to fairly compare two companies with different share counts.
Full explanation →
economics — what each share represents of the underlying business. Play with the share-price calculator on the homepage →

Loading insider & short-seller data…
Checking filings for failure warnings…

⚠ At today's price, the market values OXBR at about 4.4× its annual sales — a typical established company trades around 1–3×. Standard industry multiples (the bars below) collapse toward $0 at this scale, so they aren't the useful read. For a micro-cap with sales, lean on the Momentum trend, and cash runway — see 📍 What to focus on.

Football field: where does the price sit?

Different valuation methods produce different fair-value ranges depending on assumptions. Plotting them together lets you see at a glance whether the current price is reasonable across approaches, or only one specific lens.

$0$1$1$1$2Current price $1.57Our model's scenarios (conservative → optimistic; ◆ base, ● weighted 40/35/25)$0.29$0.29base $0.29weighted $0.29
The current price sits ABOVE the high end of every method. The market is paying a premium to all of these lenses — it expects materially better growth or margins than the models assume.

Industry multiples sourced from: industry similar to Insurance. See the Peer Basket section below for the peer comparison and its limited-comparables caveat.

⚠ Genuine comparables are scarce at this size, so peer multiples are unreliable here. Treat as rough context only — see 📍 What to focus on above.

How does OXBR stack up against its closest peers?

Ideally we compare OXBR only to same-industry peers, but too few exist in our universe right now, so the basket below mixes in broader-sector names. Treat the multiples as rough context, not a valuation.

▾ What's "EV / Sales" in plain English?

EV (Enterprise Value) = market cap + total debt − cash. It's "what you'd pay to buy the entire company outright" — you pay the market cap to shareholders and take over their debt, but you keep their cash. EV is fairer than market cap alone because it includes the debt the new owner inherits.

EV / Sales = EV ÷ annual revenue. So "2.5×" means investors pay $2.50 of enterprise value per $1 of yearly sales. Higher = market is paying more per dollar of sales (usually because they expect future growth or fat margins).

p25 / median / p75 are the 25th, 50th (middle), and 75th percentile of the peers' multiples. Half the peers fall between p25 and p75. The median (p50) is the typical peer — that's the benchmark we compare to.

What peers trade at (p25 / median / p75)

Bold middle number = median peer. Half the peers trade above it, half below. Based on the single available name (broad — see caveat) we could price — with one company there is no median, so read it as a single data point.

Peer-implied value check
Banks & insurers aren't valued on revenue or EV/Sales — a bank's "revenue" (net interest income + fees) isn't comparable the way a normal company's sales are. Use the Bank lens (P/TBV + ROE) above, which is how banks are actually judged cheap or rich.

⚠️ Important caveat: peer multiples only work if the peers are genuinely comparable. Always check the peer list below — if the auto-picker grabbed micro-caps or unrelated businesses, the comparison is noise. A medical-device giant priced against tiny biotech startups won't produce a useful signal.

▾ View peer list (1)
Ticker Company Industry Mcap EV/EBIT FCF Yield
PRHI Presurance Holdings, Inc. Property & Casualty Insura $15M

How to value a bank (not a DCF question)

A bank's economic engine is the shareholder equity on its balance sheet — what the accountants say is left over after all loans, deposits, and liabilities are netted out. The bank earns a percentage on that equity each year (its ROE). So the two questions are: (1) what are you paying per dollar of equity (Price / Book)? and (2) how much is that equity actually earning (ROE)? Free cash flow doesn't work here — banks lend out their cash for a living.

Price-to-Book (P/B)?Price-to-Book (P/B) — Share price divided by book value per share — what you pay for $1 of accounting equity.
Why it matters: For banks and insurers, book value is the regulatory capital they earn returns on. P/B is the cleanest comparison: 1.0× means buying the bank at the same price the accountants say it's worth.
Reference: 0.8–1.2× = fair for average bank · 1.5–2.0× = solid franchise · >2.5× = premium · <0.8× = potentially cheap or distress
Full explanation →
1.96×
Plain English: you pay $1.96 for every $1 of the bank's accounting equity ($0.80/share).
Premium to book — market expects above-average returns on this equity.
Return on Equity (ROE)?Return on Equity (ROE) — How much profit the company generates on every dollar of shareholder equity.
Why it matters: For a bank, ROE is the engine. A bank earning 15% on equity will compound book value at ~15%/year if it retains earnings. Combined with P/B, ROE tells you whether a premium price is supported by returns.
Reference: <8% = weak · 10–12% = solid · 15%+ = excellent · >20% sustained = exceptional franchise
Full explanation →
-35.0%
Plain English: the bank lost money last year. Every $100 of shareholder equity shrank to about $65. This is the opposite of compounding — it's a value destroyer until proven otherwise.
Return on Assets (ROA)?Return on Assets (ROA) — Net income divided by total assets — how productive each dollar of assets is.
Why it matters: For banks especially, ROA isolates underwriting and operating efficiency from leverage. Two banks with identical ROE may have very different ROAs — one earning it cleanly, one earning it on borrowed money.
Reference: <0.8% = weak · 1.0–1.2% = solid · >1.5% = excellent (very rare for big banks)
Full explanation →
-25.82%
Plain English: the bank lost 25.82% on every $100 of total assets (loans, securities, cash combined). For context: total assets are much larger than equity (banks are leveraged ~10×), so even small ROA losses translate to big ROE swings.
ROA differs from ROE because banks borrow ~10× their equity. Big asset base, smaller equity sliver.
DISTRESS SIGNAL — bank is losing money (negative ROE). The low price-to-book is the market correctly pricing in shareholder losses, not a bargain.
Plain English: this bank is shrinking, not compounding. Avoid unless you have specific knowledge of a turnaround catalyst.

Note: this lens skips Altman Z-Score and Piotroski F-Score (validated on industrial companies, not banks). For deeper bank-specific health analysis: check the 10-K's Tier 1 capital ratio, Non-Performing Loan ratio, and CET1 — these are what regulators actually monitor.

Quality & solvency checks

Cheap stocks can be cheap for a reason. These screens warn when a low valuation comes paired with structural fragility.

Altman Z-Score?Altman Z-Score — A bankruptcy-risk score combining 5 financial ratios into one number. Predictive of bankruptcy within 2 years.
Why it matters: Cheap-looking stocks (low P/E or P/B) often have low Z-scores because the market knows the company is dying. Z-score warns you before you fall into a value trap.
Reference: > 3.0 = safe zone · 1.81–3.0 = grey zone · < 1.81 = distress zone
Full explanation →
Not Applicable

Altman Z was calibrated on industrial firms and doesn't apply to banks or insurers — their balance sheets are dominated by loans/securities, not working capital. See the Bank Valuation Lens above for P/B, ROE and ROA — the metrics regulators and analysts actually use to assess bank solvency.

Piotroski F-Score?Piotroski F-Score — A 9-point quality checklist scoring profitability, leverage, and operating efficiency.
Why it matters: High score = fundamentals improving. Low score = deteriorating. Especially powerful for filtering cheap stocks: cheap + high F-score historically outperforms; cheap + low F-score is often a value trap.
Reference: 7–9 = strong · 4–6 = mediocre · 0–3 = weak
Full explanation →
Not Applicable

Piotroski F was built for non-financial firms (gross margin, asset turnover, current ratio all assume an industrial cost structure). For banks, the equivalent quality signals are efficiency ratio, net interest margin, and provision coverage — see the Bank Valuation Lens above.

Cash Runway
2 mo
CRITICAL — under 6 months of cash

Plain English: the company holds about $0M in cash and is burning roughly $1M/year in operations. At that pace, the cash lasts 2 mo before it must raise capital (diluting shareholders), take on debt, or cut spending.

Assumes constant burn and ignores financing/asset sales. For pre-profit biotech and growth companies, this matters more than a DCF — a great drug pipeline is worthless if they run out of money before approval.

What if you assume different inputs?

Here's where we land — and what happens if you change the assumptions. Drag the sliders to set your own Discount Rate?Discount Rate — The annual return you demand for taking single-stock risk instead of buying a safe Treasury or index fund.
Why it matters: Higher discount rate = stricter valuation (a stock has to produce more cash to be worth holding). Lower = more generous.
Reference: 8–12% is standard · 9–10% matches S&P 500 historical return · Below 7% is illogical for single-stock risk
Full explanation →
(the annual return you demand for single-stock risk) and terminal growth; the value updates live so you can see whether the stock looks cheaper or richer. The discount rate starts at 14.5%, the figure our model used for OXBR. Open Advanced to also change beta, growth and the rate path.

Note: the calculator opens at our published value of $0.29 — it is initialised to the same scenario-weighted result, so the two match exactly on load. The moment you move a slider, the value below becomes a single-path what-if at your assumptions (not the three-scenario weighting), which is why it can differ from the headline once you've touched it.

Scenario-weighted model IV (40/35/25 assumed weights)
$0.29
It trades at
$1.57
Premium to model IV
+436.8%
Price is 437% above model IV — it looks overvalued. Change the assumptions below to see what would justify today's price.
We value this stock at two discount rates and report the range between them:
14.5% — beta-based (CAPM), from this stock's Beta?Beta — How much the stock moves when the overall market moves. 1.0 = moves with the market; 1.5 = moves 50% more than the market.
Why it matters: Higher beta = more volatile = should demand higher discount rate. Low beta stocks (utilities, consumer staples) move less.
Reference: Most stocks 0.5–1.5 · Defensives ~0.3 · High-vol tech ~1.5–2.0
Full explanation →
of 1.81.
The safe Treasury rate plus a premium scaled by how much more (or less) volatile the stock is than the market.
13.0% — sector/quality tier. A simpler hurdle set by industry and business durability: lower for stable, wide-moat companies; higher for speculative or micro-caps.
The headline value and this calculator start at 14.5% — the beta-based rate. Drag the slider to the other rate to see the full range.
4.5% (risk-free)9-10% normal18% (deep-risk)
0%2-3% (GDP)5% (rarely sustainable)

A full intrinsic value isn't shown for OXBR because it's valued with a bank residual-income model this quick calculator doesn't replicate — see our published value above and the sector lens for the right metrics.

For comparison — the revenue growth today's price already assumes

⚙ Advanced — tinker with every input (beta, growth, rate path, margin → full intrinsic value)
Where the discount rate comes from — discount rate = risk-free + beta × equity-risk-premium
What you'd earn risk-free from government bonds — the floor under every other rate. Slide it down to model the market expecting rate cuts (value rises); up for higher-for-longer.
The extra yearly return investors demand for owning stocks instead of safe bonds — the price of risk. History runs ~4.5–6.5%; we default to 5.5% (slightly conservative). It's an estimate, not a law — lower it if you think equities are less risky than that.
Inflation reduces the purchasing power of a nominal return: a 9% gain at 3% inflation is about 6% in real terms. The intrinsic value above is already in today's dollars (a nominal DCF carries inflation in both the growth and the discount rate), so this switch does not change the value — it restates the return in real terms.
Higher beta → higher discount rate (sets the rate above). 1.0 = moves with the market.
What you think OXBR can grow revenue for ~5 years, then fades to terminal.
For a pre-profit company: the % of revenue that eventually becomes free cash flow once mature. (Our published value uses the sector norm.)
All inputs start at the values our model used.

    Copy shareable link to this scenario →

    Price$1.57
    Model IV$0.29
    Premium to IV+436.8%
    DCF applicabilityHigh
    ⚠️ Outlier ResultP/IV 5.4x — result dominated by model assumptions or data limits. Treat with caution.
    ⚠️ Outlier result (P/IV 5.4x) — this valuation gap is too extreme to produce reliable growth or return estimates. The model may not suit this company's profile.

    OXBR is deeply overvalued, with the market price at a premium of +436.8% above the model's intrinsic value?Intrinsic Value — Our DCF model's estimate of what each share is mathematically worth based on projected cash flows.
    Why it matters: Compare to current price. Below IV = potentially undervalued. Above IV = priced for growth that must actually happen.
    Reference: Model-derived; quality depends on data and assumptions.
    Full explanation →
    of $0.2925. The market may be assigning value to potential future underwriting opportunities in niche insurance markets, which is not in the model. The primary quantifiable risk is the persistent negative operating cash flow, which has been negative for 5 consecutive years.

    ⚠️ Financial sector: using residual income model. IV = Book Value + PV(excess earnings).

    As of 3 months ago

    Anatomy of a share

    What you're buying per share. Bars are at the same scale so you can see the relative size of revenue, costs, cash flow, and debt — not just read them in a table.

    OXBR OXBRIDGE RE HOLDINGS Ltd stock anatomy showing per-share revenue, operating expenses, free cash flow, and debt
    −80.7%
    loss
    Where each $1 of revenue goes
    For every $1 of revenue, OXBR currently loses 80.7¢ — costs exceed sales. A money-losing business can still be a good investment if losses are shrinking toward profitability; check the trend, not just the snapshot.
    Net margin = net income ÷ revenue (most recent fiscal year).
    Plain English: each share (at $2) represents $0.35 of revenue per share per year, $0.28 lost per share per year, and $-0.24 of owner-earnings free cash flow per current share (latest fiscal year) from the latest fiscal year. Debt-per-share isn't a meaningful figure for a bank or insurer — its liabilities (deposits, policy reserves, wholesale funding) are the business itself. Judge leverage with the capital ratios in the bank lens instead. The DCF does not start from that single year — it instead starts from a EPS basis (residual-income model) of $-0.28 per share to capture a full cycle.
    What's free cash flow / what do these mean?

    Revenue per share — how much the business earns from customers, divided by the number of shares outstanding. Top of the income statement.

    Earnings per share — profit left after operating costs, interest, and taxes, per share. Two versions appear on this page and are not interchangeable: GAAP diluted EPS uses the company's weighted-average diluted share count during the reporting period (this is the "earnings" in "price-to-earnings"); net income per current share divides annual net income by today's share count. They differ whenever the share count has changed.

    Owner-earnings free cash flow per share — the cash the business produces for shareholders. Savng's owner-earnings FCF subtracts capital expenditures and stock-based compensation from operating cash flow (SBC is a real dilution cost even though it's non-cash). This is deliberately more conservative than "standard" FCF, which subtracts only capital expenditures — so our figure is lower than the headline FCF you'll see elsewhere. FCF funds dividends, buybacks, debt repayment, and acquisitions; a company can report positive earnings yet negative FCF.

    Debt per share — total interest-bearing borrowings divided by shares. High debt-per-share next to thin FCF-per-share is a fragility signal.

    What you actually need to decide

    Every stock price is a disagreement. Here's the single thing that must go right for the bulls, the single thing that breaks the thesis, and the concrete signposts to watch so you can update your view as real results arrive.

    🐂 The Bull Case
    For the stock to work, the company's net income must consistently turn positive, reversing the trend of being profitable only 1 out of 5 years, indicating improved underwriting profitability.
    🐻 The Bear Case
    The biggest fundamental risk is the persistent negative operating cash flow (negative for 5/5 years), which implies the company is burning cash and may require external financing if it continues.
    📌 Signposts to watch — update your view as these print
    • Next quarter's net income turning positive
    • Significant increase in reinsurance premiums written
    • Improvement in operating cash flow to positive territory

    The trend, in plain numbers (FY2024 → FY2025, latest reported)

    Straight from the financial statements — no model, no opinion. For a small or unprofitable company, the direction of these numbers usually tells you more than any single valuation.

    ✅ Improving
    • Revenue grew +372% to $2.6M.
    • Still unprofitable at -$2.1M — loss narrowing.
    ⚠ Worsening
    • Free cash flow is negative at -$1.8M — the cash burn widened vs last year.

    Management & Leadership

    Limited executive data available. OXBRIDGE RE HOLDINGS Ltd is a small financial services firm, and specific executive details are not widely publicized or available in the provided data.

    What They Make

    Oxbridge Re Holdings Ltd operates as a reinsurer, providing property and casualty reinsurance solutions to clients. They primarily serve insurance companies seeking to mitigate risk exposure.

    End Markets

    Property & Casualty InsurersReinsurance MarketCatastrophe Risk Management

    Revenue Drivers

    Reinsurance premiums
    Investment income
    Underwriting results
    Market Cap: 11.6MBeta: 1.81

    Why Is It Priced Like This?

    Why Customers Pay

    Risk transfer and capital protection
    Stabilization of underwriting results
    Access to specialized reinsurance capacity
    Intrinsic Value$0.29
    Premium to IV +436.8%
    Outlier Result P/IV 5.4x — valuation gap too extreme for meaningful implied growth or return estimates.

    The market prices OXBR at a premium of +252.1% to the model's intrinsic value?Intrinsic Value — Our DCF model's estimate of what each share is mathematically worth based on projected cash flows.
    Why it matters: Compare to current price. Below IV = potentially undervalued. Above IV = priced for growth that must actually happen.
    Reference: Model-derived; quality depends on data and assumptions.
    Full explanation →
    , despite revenue declining at -29.1%/yr over 4 years and operating cash flow being negative for 5 consecutive years. The market may be assigning value to the potential for a turnaround in underwriting profitability or a strategic shift, which is not reflected in the backward-looking model. This optimism persists despite a franchise/durability score of 0/5.

    Three Scenarios, Weighted
    ScenarioIVUpside from today's priceWeight
    Conservative$0.29-81.8%40%
    Base$0.29-81.4%35%
    Optimistic$0.29-81.4%25%
    Weighted$0.29-81.4%100%

    Reading the last column: it is the move from today's price to each value (IV ÷ price − 1). The headline "premium/discount to model IV" measures the same gap from the value's side (price ÷ IV − 1), so the two percentages differ in size and sign by construction — e.g. a price 8% above value is a value 7.4% below price.

    Business Model & Valuation

    How They Make Money

    Collecting reinsurance premiums for risk coverage
    Investing premium float to generate investment income
    Underwriting and managing a portfolio of reinsurance contracts

    The company funds itself through its operations and potentially through equity raises, as it has negative operating cash flow and no dividend or buyback data is available.

    Residual Income High

    Balance-sheet financial (Property & Casualty Insurance): residual income model - book value is meaningful anchor.

    In plain English: we estimate OXBR's value by projecting its book value plus the excess return it earns on that capital into the future and converting it back to what it's worth today. We start from $-0.28 per share (EPS basis (residual-income model)), assume it grows 2.0% per year for about 5 years (then gradually fades), and discount everything at 14.5% — the yearly return a buyer should demand for this much risk. After that it's assumed to grow 1.6% per year forever (kept below long-run economic growth — the terminal rate fades from the near-term growth above, so a low near-term rate produces a low perpetual rate). A higher discount rate or slower growth means a lower value, and vice-versa — change any of these yourself in the calculator above.
    Book value / share$-0.28EPS basis (residual-income model) — smoothed, not the latest single year
    Growth (g₁) — 5yr2.0%Source: historical CAGR + sector defaults
    Discount Rate (r)14.5%
    Terminal Growth (gT)1.6%
    Show advanced inputs
    Sector Default8.0%

    What this model does NOT do: this is a consolidated owner-earnings FCF model. Standalone segment assumptions: none. It does not project premium growth, underwriting (combined ratio) and investment income independently; their combined effect is embedded in the historical revenue and cash-flow trend the model extrapolates. The calculator above can only approximate a segment's impact through the single consolidated growth rate — it cannot model any one line separately. For a true segment-level view, build a separate model from the company's segment disclosures.

    Maturity & Competitive Position

    Financial institution

    Moat Signals

    Specialized underwriting expertise
    Relationships with ceding insurers
    Capital strength for risk bearing

    Revenue has been declining at -29.1%/yr over the last four years, from $10M to $3M.

    Geography & Markets

    Oxbridge Re Holdings Ltd operates within the global reinsurance market, though specific geographic revenue mix data is not available from current data sources. It is likely focused on specific regional or niche markets.

    Geographic Risks

    Concentration risk in specific reinsurance lines or geographies (details not available)
    Exposure to catastrophic events impacting underwriting results

    Market Signals

    These are timing signals, not value signals — they describe the stock's recent price behavior, not what the business is worth. Use them for the "the thesis looks good, but is now the moment?" question. Each tile below explains what it's saying.

    Model bearish, tape neutral
    RSI?RSI — Relative Strength Index — a 0-100 momentum gauge. Above 70 = overbought; below 30 = oversold.
    Why it matters: Short-term contrarian indicator. Extreme readings often precede mean reversion, though not always.
    Reference: 30–70 normal · >70 overbought · <30 oversold
    Full explanation →
    (14)
    58.8NeutralMomentum is balanced — neither overbought nor oversold.
    MACD?MACD — Moving Average Convergence Divergence — compares a fast and a slow price trend to gauge momentum direction.
    Why it matters: When the fast line crosses above the slow line, short-term momentum is turning up; below, turning down. A timing cue, not a value signal.
    Reference: Line above signal = bullish momentum · below = bearish
    Full explanation →
    BullishLine above signalThe fast trend is above the slow trend — short-term momentum is currently upward.
    50-Day Average$0.90Price above (+74.4%)Price above its 50-day average = near-term uptrend.
    200-Day Average$1.34Price aboveThe 200-day line is the long-term trend divider — above it is generally considered a bull market for the stock.
    50 vs 200 CrossDeath50-day below 200-dayA "death cross" — the medium trend is below the long trend (often read as bearish).

    Technicals describe price, not the business. A great company can have a "bearish" tape (a buying chance) and a weak one a "bullish" tape (a trap). Pair these with the valuation and health sections above.

    Data Quality & Risk Flags (4 notes — click to expand/collapse)

    Guardrail Notes (4)
    • Financial sector: using residual income model. IV = Book Value + PV(excess earnings).
    • Terminal growth (3%) capped to 1.6% (80% of near-term growth 2%).
    • Model implies no positive equity value under these assumptions. Valuation is speculative/low-confidence.
    • Illiquidity discount 25% applied (small/micro-cap — harder to exit, demand a margin).

    Financial Statements (5-year tables — click to expand)

    From OXBRIDGE RE HOLDINGS Ltd's SEC filings (EDGAR).

    Income (5yr)

    YearRevenueNet IncomeEPS
    20252.6M-2.1M$-0.28
    2024546,000-2.7M$-0.45
    2023-7.0M-9.9M$-1.69
    2022850,000-1.8M$-0.31
    202110.2M8.6M$1.49

    Cash Flow (5yr)

    YearOperating CFCapEx− SBC & adj.Free Cash Flow
    2025 -1.3M 16,000 418,000 -1.8M
    2024 -284,000 234,000 -518,000
    2023 -1.3M 5,000 258,000 -1.5M
    2022 -829,000 127,000 -956,000
    2021 -253,000 3,000 61,000 -317,000

    How we define FCF: operating cash flow − capital expenditure − stock-based compensation (owner-earnings basis — SBC is a real cost to shareholders even though it's non-cash). Latest year: -1.3M − 16,000 − 418,000 (SBC & adj.) = -1.8M. This is the same owner-earnings FCF definition the valuation model uses, though the DCF's starting value is a EPS basis (residual-income model), not this single year.

    Balance Sheet

    Total Assets8.1M
    Total Liabilities1.6M
    Equity5.9M

    Similar companies worth a look

    Same sector and industry, similar fundamentals shape. Verify everything yourself — this list is computed mechanically and does not reflect our judgment about whether any of these are a good investment.

    PG
    Methodology by Pouyan Golshani, MD — founder of Gighz. Savng was built by a physician for busy professionals: every number on this page comes from SEC filings (EDGAR) and FINRA data through transparent, rules-based models — no analyst opinions, no hidden inputs. How we calculate every number →
    ⚠️ Not investment advice. Automated model outputs, last refreshed May 30, 2026 (the analysis-refresh date, not the latest filing period). All models have blind spots. Full disclaimer →
    🔔 Follow $OXBR — free insider alerts
    One email when an insider buys $OXBR on the open market with their own cash — or notably sells outside a scheduled plan. Routine and automated trades filtered out. Follow up to 3 stocks free; Portfolio Watch covers your whole list plus valuation & risk alerts. Double opt-in, unsubscribe anytime.